دورية أكاديمية
EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance
| العنوان: | EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance |
|---|---|
| المؤلفون: | Chu, Liping, Tan, Dongxia, Zhu, Meimei, Qu, Yuxiu, Ma, Xin, Song, Bao-Liang, Qi, Wei |
| المصدر: | Journal of Biological Chemistry ; volume 299, issue 4, page 103073 ; ISSN 0021-9258 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cell Biology, Molecular Biology, Biochemistry |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.jbc.2023.103073 |
| الإتاحة: | https://doi.org/10.1016/j.jbc.2023.103073Test https://api.elsevier.com/content/article/PII:S0021925823002053?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0021925823002053?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.D340306F |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jbc.2023.103073 |
|---|